Key facts
- Epione Medicine’s last known valuation is $4.3M (Mar 2025).
- It has raised $900K; the latest was Later Stage VC ($870K) in Mar 2025.
- Notable investors include Strive Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Epione Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Epione Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Epione Medicine
Developer of a medicine supply operation designed to provide high quality medicines at lower cost to support patient wellbeing and reduce healthcare spending. The company offers reliable sourcing, quality focused processes, and efficient distribution, enabling healthcare providers and public healthcare organizations to access essential medicines while lowering overall treatment costs.
- Sector
- Healthcare
- HQ
- Hvidovre, Denmark
- Founded
- 2020
- Employees
- 42
- Website
- epionemedicine.com/
- Ownership
- Privately Held (backing)
Epione Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Epione Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Epione Medicine in its N-PORT filings yet. We sweep new filings monthly.